TG Therapeutics (TGTX) announced updated data presentations including new six-year data from the ULTIMATE I & II Phase 3 trials evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback